According to apreliminary study by Lu et al. [26], patients, who had colorectal carcinoma synchronous liver metastasis withhigh expression of FXYD6, were sensitive to the FOLFOX4 chemotherapy regimen by usingDNA microarray analysis. Here, FXYD6 is linked to colorectal carcinoma.